110 related articles for article (PubMed ID: 23280075)
1. TGF-β1 expression in kidney allograft protocol biopsies during cyclosporine A therapy.
Ortiz F; Helanterä IT; Räisänen-Sokolowski A; Honkanen EO; Koskinen PK
Int J Artif Organs; 2013 Jan; 36(1):56-62. PubMed ID: 23280075
[TBL] [Abstract][Full Text] [Related]
2. The effect of different immunosuppressive regimens on TGF-beta1 expression in kidney transplant patients.
Matl I; Viklický O; Voska L; Lodererová A; Vítko S
Transpl Int; 2005 Jun; 18(6):668-71. PubMed ID: 15910291
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta1 expression and chronic allograft nephropathy in protocol kidney graft biopsy.
Viklický O; Matl I; Voska L; Böhmová R; Jaresová M; Lácha J; Lodererová A; Stríz I; Teplan V; Vítko S
Physiol Res; 2003; 52(3):353-60. PubMed ID: 12790768
[TBL] [Abstract][Full Text] [Related]
4. Serum TGF-beta1 correlates with chronic histopathological lesions in protocol biopsies of kidney allograft recipients.
Baczkowska T; Perkowska-Ptasińska A; Sadowska A; Lewandowski Z; Nowacka-Cieciura E; Cieciura T; Pazik J; Lewandowska D; Mroz A; Urbanowicz A; Nazarewski S; Danielewicz R
Transplant Proc; 2005 Mar; 37(2):773-5. PubMed ID: 15848527
[TBL] [Abstract][Full Text] [Related]
5. Molecular and structural consequences of early renal allograft injury.
Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
[TBL] [Abstract][Full Text] [Related]
6. Captopril enhances transforming growth factor (TGF)-beta1 expression in peripheral blood mononuclear cells: a mechanism independent from angiotensin converting enzyme inhibition? A study in cyclosporine-treated kidney-transplanted patients.
Di Paolo S; Schena A; Stallone G; Grandaliano G; Soccio M; Cerullo G; Gesualdo L; Paolo Schena F
Transplantation; 2002 Dec; 74(12):1710-5. PubMed ID: 12499886
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 expression in renal allograft rejection and cyclosporine A toxicity.
Ozdemir BH; Ozdemir FN; Demirhan B; Haberal M
Transplantation; 2005 Dec; 80(12):1681-5. PubMed ID: 16378061
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta1 mRNA upregulation influences chronic renal allograft dysfunction.
Pribylova-Hribova P; Kotsch K; Lodererova A; Viklicky O; Vitko S; Volk HD; Lacha J
Kidney Int; 2006 May; 69(10):1872-9. PubMed ID: 16612332
[TBL] [Abstract][Full Text] [Related]
9. The impact of cyclosporine dose reduction with or without the addition of rapamycin on functional, molecular, and histological markers of chronic allograft nephropathy.
Saunders RN; Bicknell GR; Nicholson ML
Transplantation; 2003 Mar; 75(6):772-80. PubMed ID: 12660500
[TBL] [Abstract][Full Text] [Related]
10. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy.
Luna E; Cerezo I; Macias R; Villa J; Martinez C; Cubero J; Martinez R; Ferreira F; García C
Transplant Proc; 2011; 43(6):2187-90. PubMed ID: 21839229
[TBL] [Abstract][Full Text] [Related]
11. Molecular and clinical response to angiotensin II receptor antagonist in kidney transplant patients with chronic allograft nephropathy.
Mas VR; Alvarellos T; Maluf DG; Ferreira-Gonzalez A; Oliveros L; Maldonado RA; de Boccardo G
Transpl Int; 2004 Oct; 17(9):540-4. PubMed ID: 15349718
[TBL] [Abstract][Full Text] [Related]
12. Urinary transforming growth factor-beta1 excretion in renal allograft recipients during the early post-transplantation period.
Goumenos DS; Tsakas S; Karavias D; Savidaki I; Karatzas T; Vlachojannis JG
Ren Fail; 2003 Jul; 25(4):561-8. PubMed ID: 12911160
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta1 and tumor growth factor-beta-inducible gene-H3 in nonrenal transplant cyclosporine nephropathy.
Langham RG; Egan MK; Dowling JP; Gilbert RE; Thomson NM
Transplantation; 2001 Dec; 72(11):1826-9. PubMed ID: 11740395
[TBL] [Abstract][Full Text] [Related]
14. Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant.
Rivelli RF; Gonçalves RT; Leite M; Santos MA; Delgado AG; Cardoso LR; Takiya CM
Nephrology (Carlton); 2015 Mar; 20(3):168-76. PubMed ID: 25404086
[TBL] [Abstract][Full Text] [Related]
15. Intragraft messenger RNA expression of angiotensinogen: relationship with transforming growth factor beta-1 and chronic allograft nephropathy in kidney transplant patients.
Mas V; Alvarellos T; Giraudo C; Massari P; De Boccardo G
Transplantation; 2002 Sep; 74(5):718-21. PubMed ID: 12352892
[TBL] [Abstract][Full Text] [Related]
16. Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity.
Pankewycz OG; Miao L; Isaacs R; Guan J; Pruett T; Haussmann G; Sturgill BC
Kidney Int; 1996 Nov; 50(5):1634-40. PubMed ID: 8914030
[TBL] [Abstract][Full Text] [Related]
17. Effects of candesartan and perindopril on renal function, TGF-beta1 plasma levels and excretion of prostaglandins in stable renal allograft recipients.
Hetzel GR; Hermsen D; Hohlfeld T; Rettich A; Ozcan F; Fusshöller A; Grabensee B; Plum J
Clin Nephrol; 2002 Apr; 57(4):296-302. PubMed ID: 12005246
[TBL] [Abstract][Full Text] [Related]
18. Effect of adjunctive roxithromycin therapy on interleukin-1β, transforming growth factor-β1 and vascular endothelial growth factor in gingival crevicular fluid of cyclosporine A-treated patients with gingival overgrowth.
Gong Y; Lu J; Ding X; Yu Y
J Periodontal Res; 2014 Aug; 49(4):448-57. PubMed ID: 23947915
[TBL] [Abstract][Full Text] [Related]
19. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of changing from cyclosporine C0 to C2 monitoring in stable recipients following renal transplantation: a prospective cohort study.
Zhang Y; Zhang XD; Wang Y
Transplant Proc; 2011 Dec; 43(10):3697-701. PubMed ID: 22172829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]